DMAC•businesswire•
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
Summary
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that Rick Pauls, President and CEO, will participate in the Jefferies Global Healthcare Conference in London, taking place November 17-20, 2025. Mr. Pauls will deliver a corporate presentation and participate in one-on-one investor meetings during the confe
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 10, 2025 by businesswire